Project COMET: Massed Prolonged Exposure for PTSD and SUD
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT06968832
- Status
- Recruiting
Conditions
- Comorbidity
- Posttraumatic Stress Disorder (PTSD)
- Substance Use Disorders (SUD)
- Trauma and Stressor Related Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Massed Prolonged Exposure Therapy (M-PE) — BEHAVIORALMassed Prolonged Exposure (M-PE) is a trauma-focused, evidence-based behavioral intervention for posttraumatic stress disorder (PTSD). It is delivered over a compressed timeline (e.g., 10 sessions over 2-4 weeks) as opposed to weekly sessions over 3-4 months. This format has been shown to accelerate PTSD symptom reduction and reduce treatment dropout. In this study, M-PE will be delivered concurrently with an Intensive Outpatient Program (IOP) for substance use disorder (SUD) at Gateway Community Services. Sessions will be led by trained clinicians using a standardized PE protocol, with treatment including imaginal exposure, in vivo exposure, and processing.
- Standard outpatient SUD care — BEHAVIORALPatients randomized to usual care will receive standard intensive outpatient SUD treatment. * Resilience group (weekly) * Peer support * Individual therapy from a variety of modalities
Study Details
The goal of this clinical trial is to learn if Massed Prolonged Exposure Therapy (M-PE) can improve PTSD symptoms and reduce substance use in adults receiving intensive outpatient (IOP) treatment for substance use disorder (SUD). The main questions it aims to answer are: * Does M-PE reduce PTSD symptoms more effectively than trauma treatment as usual (TAU)? * Does M-PE reduce the number of days participants use substances? * How do patient-centered outcomes (such as depression, suicidal thoughts, and quality of life) differ between M-PE and trauma TAU? * Researchers will compare M-PE to treatment as usual to see if M-PE leads to better mental health and substance use outcomes and lower dropout rates. Participants will: * Attend multiple therapy sessions per week (M-PE) or receive usual care * Complete assessments at baseline, during treatment, end-of-treatment, 1-month, 3-month, and 6-month follow-up * Share feedback through surveys and interviews about their experience in the program
Key Dates
- Start date
- Sep 2, 2025
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2029
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 168 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Massed Prolonged Exposure (M-PE) + Intensive Outpatient Program (IOP)Participants randomized to this arm will receive Massed Prolonged Exposure (M-PE) therapy, a gold-standard treatment for PTSD delivered multiple times per week over 2-4 weeks. M-PE will be integrated into the standard Intensive Outpatient Program (IOP) for substance use disorder (SUD) at Gateway Community Services, Inc. This arm is designed to evaluate the effectiveness of delivering M-PE concurrently with SUD treatment in improving PTSD symptoms, reducing substance use, and improving patient-centered outcomes.
- Active Comparator: Trauma Treatment as Usual (TAU) - IOP with Trauma Skills GroupParticipants randomized to this arm will receive the standard Intensive Outpatient Program (IOP) for substance use disorder (SUD), which includes a weekly trauma skills group as part of usual care. This comparator arm allows for evaluation of whether M-PE enhances outcomes beyond those achieved through trauma-informed IOP care.
Primary Outcome Measure
Clinician Administered PTSD Scale for DSM-5 (CAPS-5) [ Time Frame: Baseline; End of Treatment (6 weeks post-randomization); 1-month (10 weeks), 3-month (18 weeks), and 6-month (30 weeks) post-randomization follow-up ]
Central Contacts
- Denise Hien Helen E. Chaney Endowed Chair in Alcohol Studies, Ph.D848-445-0749
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Gateway Community Services | Jacksonville | Florida | 32204 | Candy Hodgkins CEO - Gateway Comunity Services, Inc., Doctor of Philosophy (Ph.D.) 1-877-389-9966 |
Find similar trials in Jacksonville, FL
Related Studies
- Methylphenidate for the Treatment of PTSD With Associated Neurocognitive ComplaintsPHASE4 · Recruiting · VA Office of Research and Development · Birmingham, Alabama
- A Neurosensory Account of Anxiety and Stress (Study 1)Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Synergy Between Patient and Clinician: Using a Trauma-Informed Care PlanEnrolling By Invitation · Brigham and Women's Hospital · Boston, Massachusetts
- Effects of "Alliance180 Program" on Well-BeingRecruiting · University of North Carolina, Chapel Hill · Saratoga Springs, New York